TD
Translational Development Acquisition Corp.
TDACW · NASDAQ
$1.45 +346.15% (+$1.13)
1M -9.09%
Market Cap $38.2M
P/E Ratio 6.90x
Div. Yield -
ROE 3.28%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.26x
P/E 6.90x
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
36 /100
Average Asset turnover 0.00x
ROE 3.28%
ROA 3.52%
Debt
0 /100
High Current ratio 0.06x
Net debt/EBITDA N/A
Debt/Equity N/A
Stability
0 /100
Unstable Beta 2.11x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TDACW
Online
Sector
Financial Services
Industry
Shell Companies
CEO
Michael Hoffman
Employees
2
Headquarters
New York City